Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
Var2 Pharmaceuticals
IGM Biosciences, Inc.
Taproot Health
TopAlliance Biosciences
Celgene
Celldex Therapeutics
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc